Superior vena cava syndrome surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:


[[Category:Disease]]
[[Category:Disease]]
[[Category:Oncology]]
[[Category:Otolaryngology]]
[[Category:Otolaryngology]]
[[Category:Hematology]]
[[Category:Hematology]]
Line 22: Line 21:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 18:55, 28 August 2015

Superior Vena Cava Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Superior Vena Cava Syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Superior vena cava syndrome surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Superior vena cava syndrome surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Superior vena cava syndrome surgery

CDC on Superior vena cava syndrome surgery

Superior vena cava syndrome surgery in the news

Blogs on Superior vena cava syndrome surgery

Directions to Hospitals Treating Superior vena cava syndrome

Risk calculators and risk factors for Superior vena cava syndrome surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Surgical options include stent placement and surgical bypass.

Surgery

Stent Placement

There have been numerous small studies using an intravascular expandable stent to reopen the occluded SVC; however, no prospectively designed comparative studies have been published. The reported response rates have been about 90% or greater. There is no agreement on the need for anticoagulant therapy after stent placement. In one series that used anticoagulant therapy for patients as part of the treatment protocol, there were reports of re-occlusion after this therapy was stopped. However, in another study, 17 cancer patients who were treated with stents and who did not have anticoagulant therapy had no occlusions.

Surgical Bypass

Surgical bypass of an obstructed SVC is more appropriate for patients with a benign obstruction than with a malignant obstruction, although surgical bypass has also been used for patients with malignant obstructions.

References

Template:WH Template:WS